Please login to the form below
European biotech
This page shows the latest European biotech news and features for those working in and with pharma, biotech and healthcare.
EU identifies first five ‘promising’ COVID-19 drugs as part of therapeutics strategy
This includes Lilly’s bamlanivimab and etesevimab combination, Roche and Regeneron’s REGEN-COV (casirivimab and imdevimab), Celltrion’s regdanivimab and GlaxoSmithKline/Vir Biotech’s sotrovimab. ... The European Medicines Agency (EMA) is
Latest news
-
eureKARE to use $60m financing to bolster next-generation European biotech companies
eureKARE has launched with a $60m Series A financing round to bolster the next-generation of European biotech companies working in the fields of the microbiome and synthetic biology. ... eureKARE has set up biotech start-up studio models – eureKABIOME
-
CureVac and Bayer partner on mRNA-based COVID-19 vaccine
The vaccine also demonstrated early indications of functional T cells, confirming activation of cellular immune response according to the German biotech company. ... The European Commission (EC) has already secured 405 million doses of CVnCoV which will
-
Mega-mergers dominate as buoyant markets lift biopharma
The biotech has also managed to increase its share price since its launch, a feat not frequently achieved in the sector. ... a new surge in confidence in European biotech.
-
Novartis and J&J back latest €400m Medicxi biopharma fund
stage European biotechs, which have tended not have access to as much financial support as their counterparts in the US. ... to Medicxi, with European companies growing in stature and offering improved returns on investment for backers.
-
Illumina sets up first ex-US accelerator site in Cambridge
Boost for UK's golden triangle biotech region. Illumina has set up its first hub for genomics start-up funding outside the US, and has chosen Cambridge in the UK for
More from news
Approximately 22 fully matching, plus 36 partially matching documents found.
Latest Intelligence
-
A snapshot of Healx
Healx is based in Cambridge, UK, a key European biotech hub, and was founded in 2014 by Dr Tim Guilliams, a biochemical engineer and founder of the Cambridge Rare Disease Network, ... Why will the company make it in the high-risk, highly competitive
-
Building European biotech firms to rival those of the US
Germany is European biotech’s sleeping giant. “Germany is Europe’s great untapped player in biotech,” said Richard. ... produced far fewer biotech companies than you would expect, it’s definitely the place to watch.”.
-
European biotech: a new generation of leaders emerges
biotechs’. The growing role of specialist venture capital. One of the key ingredients in these and other recent European biotech success stories is long-term backing from investors. ... European biotech is benefiting from this new support to translate
-
Building Europe’s next breakthrough biotechs
Cambridge's new Biomedical Campus is home to specialist NHS trusts, AstraZeneca's new HQ and biotech firms. ... How can the UK life science ecosystem produce even more biotech start-ups, and propel them to long-term success?
-
25 Women Leaders in UK Healthcare
It’s long been recognised that one of the biggest factors holding back UK and European biotech success has been a paucity of leaders, and that’s why efforts are being ... As well as overseeing the European communications group for Syneos Health, she
More from intelligence
Approximately 2 fully matching, plus 8 partially matching documents found.
Latest appointments
-
Paris biocluster appoints Stéphane Roques as new chief
Former general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment
-
Apeiron bolsters management board
With more than 25 years’ experience in initial public offerings, mergers and acquisitions, as well as licensing and financial transactions in the chemical, biotech and pharma industries, Llewellyn-Davies most recently ... He said: “Apeiron is
-
Novimmune expands senior management team
He is currently a board member of German biotech Epiontis, and has previously served as chief financial officer of PregLem and chairman of Aimago. ... Prior to this, Dr Zimmerman was a European biotech analyst at UBS Investment Bank.
-
MRC Technology appoints director of technology transfer
Farquharson is additionally appointed to the EU Commission's Expert Group, advising on the European Biotech Directive's impact on patent law and R&D activities.
-
Creabilis names Catherine Moukheibir as chairman of the board
After an initial career in strategy consulting and investment banking, she held a number of senior management role at European biotech firms including CFO at Movetis, non-executive board member at
More from appointments
Approximately 1 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Europe’s cancer community publishes new report on transforming patient care
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- EU to revise pharmaceuticals law amid antibiotic shortages
- European MPs call for urgent action against antimicrobial resistance
- The role of medical communications in building credibility for healthtech
PMHub
Create Health
A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
